Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Predictors of failure in timely tuberculosis treatment completion, United States.

Mitruka K, Winston CA, Navin TR.

Int J Tuberc Lung Dis. 2012 Aug;16(8):1075-82. doi: 10.5588/ijtld.11.0814. Epub 2012 Jun 5.

PMID:
22668774
2.

Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.

LoBue PA, Enarson DA, Thoen TC.

Int J Tuberc Lung Dis. 2010 Oct;14(10):1226-32. Review.

PMID:
20843412
3.

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell PC, Nahid P.

Clin Infect Dis. 2009 Jan 15;48(2):179-85. doi: 10.1086/595689.

4.

Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.

Hoopes AJ, Kammerer JS, Harrington TA, Ijaz K, Armstrong LR.

Arch Intern Med. 2008 Oct 13;168(18):1984-92. doi: 10.1001/archinte.168.18.1984.

PMID:
18852399
5.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. No abstract available.

PMID:
12588714
6.

Completion of tuberculosis therapy for patients reported in the United States in 1993.

Bloch AB, Cauthen GM, Simone PM, Kelly GD, Dansbury KG, Castro KG.

Int J Tuberc Lung Dis. 1999 Apr;3(4):273-80.

PMID:
10206496

Supplemental Content

Support Center